The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Anti-Migraine Drugs-Global Market Insights and Sales Trends 2025

Anti-Migraine Drugs-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1830152

No of Pages : 106

Ask Your Query
Synopsis
The global Anti-Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Migraine Drugs in various end use industries. The expanding demands from the Women and Men, are propelling Anti-Migraine Drugs market. Triptans, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ergots segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Migraine Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Migraine Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Migraine Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Migraine Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Migraine Drugs covered in this report include Eli Lilly, Abbott, Eisai, Allergan, Endo, GlaxoSmithKline, Impax Laboratories, Pfizer and AstraZeneca, etc.
The global Anti-Migraine Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Abbott
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen
Global Anti-Migraine Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Migraine Drugs market, Segment by Type:
Triptans
Ergots
Others
Global Anti-Migraine Drugs market, by Application
Women
Men
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-Migraine Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-Migraine Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti-Migraine Drugs Market Overview
1.1 Anti-Migraine Drugs Product Overview
1.2 Anti-Migraine Drugs Market Segment by Type
1.2.1 Triptans
1.2.2 Ergots
1.2.3 Others
1.3 Global Anti-Migraine Drugs Market Size by Type
1.3.1 Global Anti-Migraine Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-Migraine Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti-Migraine Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti-Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti-Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti-Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti-Migraine Drugs Sales Breakdown by Type (2018-2023)
2 Global Anti-Migraine Drugs Market Competition by Company
2.1 Global Top Players by Anti-Migraine Drugs Sales (2018-2023)
2.2 Global Top Players by Anti-Migraine Drugs Revenue (2018-2023)
2.3 Global Top Players by Anti-Migraine Drugs Price (2018-2023)
2.4 Global Top Manufacturers Anti-Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Migraine Drugs Market Competitive Situation and Trends
2.5.1 Anti-Migraine Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Migraine Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Migraine Drugs Market
2.8 Key Manufacturers Anti-Migraine Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Migraine Drugs Status and Outlook by Region
3.1 Global Anti-Migraine Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-Migraine Drugs Historic Market Size by Region
3.2.1 Global Anti-Migraine Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-Migraine Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Anti-Migraine Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-Migraine Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Migraine Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-Migraine Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Anti-Migraine Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-Migraine Drugs by Application
4.1 Anti-Migraine Drugs Market Segment by Application
4.1.1 Women
4.1.2 Men
4.2 Global Anti-Migraine Drugs Market Size by Application
4.2.1 Global Anti-Migraine Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-Migraine Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-Migraine Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-Migraine Drugs Sales Breakdown by Application (2018-2023)
5 North America Anti-Migraine Drugs by Country
5.1 North America Anti-Migraine Drugs Historic Market Size by Country
5.1.1 North America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-Migraine Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-Migraine Drugs Sales in Value by Country (2018-2023)
5.2 North America Anti-Migraine Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Migraine Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-Migraine Drugs Sales in Value by Country (2024-2029)
6 Europe Anti-Migraine Drugs by Country
6.1 Europe Anti-Migraine Drugs Historic Market Size by Country
6.1.1 Europe Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-Migraine Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-Migraine Drugs Sales in Value by Country (2018-2023)
6.2 Europe Anti-Migraine Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Migraine Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-Migraine Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-Migraine Drugs by Region
7.1 Asia-Pacific Anti-Migraine Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-Migraine Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-Migraine Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-Migraine Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Migraine Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-Migraine Drugs Sales in Value by Region (2024-2029)
8 Latin America Anti-Migraine Drugs by Country
8.1 Latin America Anti-Migraine Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-Migraine Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-Migraine Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Anti-Migraine Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-Migraine Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-Migraine Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-Migraine Drugs by Country
9.1 Middle East and Africa Anti-Migraine Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-Migraine Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-Migraine Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-Migraine Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Migraine Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-Migraine Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
10.1.5 Eli Lilly Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Introduction and Business Overview
10.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Anti-Migraine Drugs Products Offered
10.2.5 Abbott Recent Development
10.3 Eisai
10.3.1 Eisai Company Information
10.3.2 Eisai Introduction and Business Overview
10.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eisai Anti-Migraine Drugs Products Offered
10.3.5 Eisai Recent Development
10.4 Allergan
10.4.1 Allergan Company Information
10.4.2 Allergan Introduction and Business Overview
10.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Allergan Anti-Migraine Drugs Products Offered
10.4.5 Allergan Recent Development
10.5 Endo
10.5.1 Endo Company Information
10.5.2 Endo Introduction and Business Overview
10.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Endo Anti-Migraine Drugs Products Offered
10.5.5 Endo Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Anti-Migraine Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Impax Laboratories
10.7.1 Impax Laboratories Company Information
10.7.2 Impax Laboratories Introduction and Business Overview
10.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Impax Laboratories Anti-Migraine Drugs Products Offered
10.7.5 Impax Laboratories Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Anti-Migraine Drugs Products Offered
10.8.5 Pfizer Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AstraZeneca Anti-Migraine Drugs Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Bayer
10.10.1 Bayer Company Information
10.10.2 Bayer Introduction and Business Overview
10.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bayer Anti-Migraine Drugs Products Offered
10.10.5 Bayer Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Johnson & Johnson Anti-Migraine Drugs Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Merck Anti-Migraine Drugs Products Offered
10.12.5 Merck Recent Development
10.13 Teva
10.13.1 Teva Company Information
10.13.2 Teva Introduction and Business Overview
10.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Teva Anti-Migraine Drugs Products Offered
10.13.5 Teva Recent Development
10.14 Amgen
10.14.1 Amgen Company Information
10.14.2 Amgen Introduction and Business Overview
10.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Amgen Anti-Migraine Drugs Products Offered
10.14.5 Amgen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Migraine Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Migraine Drugs Industrial Chain Analysis
11.4 Anti-Migraine Drugs Market Dynamics
11.4.1 Anti-Migraine Drugs Industry Trends
11.4.2 Anti-Migraine Drugs Market Drivers
11.4.3 Anti-Migraine Drugs Market Challenges
11.4.4 Anti-Migraine Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Migraine Drugs Distributors
12.3 Anti-Migraine Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock